Swiss Life Asset Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$366K Sell
1,932
-242
-11% -$35.9K ﹤0.01% 1138
2026
Q1
$202K Buy
+2,174
New +$193K ﹤0.01% 1383

Other funds holding ACLS

Swiss Life Asset Management's ACLS Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Axcelis (ACLS) stake by 11% in Q2 2026, selling an estimated $35.9K and leaving 1,932 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

Swiss Life Asset Management first reported a position in ACLS in Q1 2026 and has held it in 2 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Swiss Life Asset Management held 1,932 shares of Axcelis worth $366K as of Q2 2026.
  • Swiss Life Asset Management sold 242 Axcelis shares in Q2 2026, an estimated $35.9K.
  • Axcelis made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1138 holding.
  • Swiss Life Asset Management first reported a position in Axcelis in Q1 2026 and has held it in 2 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.